Literature DB >> 12054477

Regulation of the murine alpha(2)(I) collagen promoter by retinoic acid and retinoid X receptors.

Lan Wang1, Lynda Rennie Tankersley, Mei Tang, James J Potter, Esteban Mezey.   

Abstract

Retinoic acid decreases collagen production by hepatic stellate cells. This study investigated the effects of retinoic acid receptor beta (RARbeta) and retinoid X receptor alpha (RXRalpha) on the regulation of the alpha(2)(I) collagen promoter. Retinoic acid and the RARbeta and RXRalpha expression vectors suppressed the promoter in transfected stellate cells with maximal suppression obtained when combined. Mutation of the retinoic acid response element (RARE) at -879 to -874 (site 1) enhanced promoter activity and diminished but did not eliminate the suppression by RARbeta and RXRalpha. Mutation of another RARE site (site 2), at -930 to -911, resulted in low activity that was inhibited by retinoic acid. Mutation of the AP-2-binding site enhanced promoter activity that was inhibited by retinoic acid. This study shows that the suppressive effect of retinoic acid on the promoter is maximal with a combination of RARbeta and RXRalpha and occurs at more than one RARE site. The effect of retinoic acid is not mediated by AP-2. (c) 2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12054477     DOI: 10.1016/S0003-9861(02)00058-9

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  14 in total

Review 1.  The interaction between HCV and nuclear receptor-mediated pathways.

Authors:  Zoe Raglow; Carly Thoma-Perry; Richard Gilroy; Yu-Jui Yvonne Wan
Journal:  Pharmacol Ther       Date:  2011-05-18       Impact factor: 12.310

2.  Retinoic acid and tumor necrosis factor-α induced monocytic cell gene expression is regulated in part by induction of transcription factor MafB.

Authors:  Y Zhang; Q Chen; A C Ross
Journal:  Exp Cell Res       Date:  2012-07-20       Impact factor: 3.905

3.  Retinoic acid and the transcription factor MafB act together and differentially to regulate aggrecan and matrix metalloproteinase gene expression in neonatal chondrocytes.

Authors:  Yao Zhang; A Catharine Ross
Journal:  J Cell Biochem       Date:  2013-02       Impact factor: 4.429

4.  Additive inhibitory effect of experimentally induced hepatic cirrhosis by agonists of peroxisome proliferator activator receptor gamma and retinoic acid receptor.

Authors:  Rafael Bruck; Sigal Weiss; Hussein Aeed; Mark Pines; Zamir Halpern; Isabel Zvibel
Journal:  Dig Dis Sci       Date:  2008-07-02       Impact factor: 3.199

Review 5.  Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver.

Authors:  Scott L Friedman
Journal:  Physiol Rev       Date:  2008-01       Impact factor: 37.312

Review 6.  The Power of Plasticity-Metabolic Regulation of Hepatic Stellate Cells.

Authors:  Parth Trivedi; Shuang Wang; Scott L Friedman
Journal:  Cell Metab       Date:  2020-11-23       Impact factor: 27.287

7.  Treatment with 4-methylpyrazole modulated stellate cells and natural killer cells and ameliorated liver fibrosis in mice.

Authors:  Hyon-Seung Yi; Hyuk Soo Eun; Young-Sun Lee; Ju Yeon Jung; Seol-Hee Park; Keun-Gyu Park; Hueng-Sik Choi; Jae Myoung Suh; Won-Il Jeong
Journal:  PLoS One       Date:  2015-05-29       Impact factor: 3.240

Review 8.  Vitamin a deficiency and alterations in the extracellular matrix.

Authors:  Teresa Barber; Guillermo Esteban-Pretel; María Pilar Marín; Joaquín Timoneda
Journal:  Nutrients       Date:  2014-11-10       Impact factor: 5.717

9.  Safety Evaluation and Anti-wrinkle Effects of Retinoids on Skin.

Authors:  Bae-Hwan Kim
Journal:  Toxicol Res       Date:  2010-03

10.  Altered vitamin A metabolism in human liver slices corresponds to fibrogenesis.

Authors:  Lindsay C Czuba; Xia Wu; Weize Huang; Nicole Hollingshead; Jessica B Roberto; Heidi L Kenerson; Raymond S Yeung; Ian N Crispe; Nina Isoherranen
Journal:  Clin Transl Sci       Date:  2021-02-02       Impact factor: 4.689

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.